Study protocol for a randomized controlled trial for anterior inguinal hernia repair: transrectus sheath preperitoneal mesh repair compared to transinguinal preperitoneal procedure by Prins, M.W. et al.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/117696
 
 
 
Please be advised that this information was generated on 2017-12-05 and may be subject to
change.
STUDY PROTOCOL Open Access
Study protocol for a randomized controlled trial
for anterior inguinal hernia repair: transrectus
sheath preperitoneal mesh repair compared to
transinguinal preperitoneal procedure
M Wiesje Prins1*, Giel G Koning1, Eric F Keus1, Patrick WHE Vriens2,3, Roland MHG Mollen4, Willem L Akkersdijk5
and Cees JHM van Laarhoven1
Abstract
Background: Anterior open treatment of the inguinal hernia with a tension-free mesh has reduced the incidence
of hernia recurrence. The Lichtenstein procedure is the current reference technique for inguinal hernia treatment.
Chronic pain has become the main postoperative complication after surgical inguinal hernia repair, especially
following Lichtenstein. Preliminary experiences with a soft mesh positioned in the preperitoneal space (PPS) by
transinguinal preperitoneal (TIPP) or total extraperitoneal (TEP) technique, showed promising results considering the
reduction of postoperative chronic pain. Evolution of surgical innovations for inguinal hernia repair led to an open,
direct approach with preperitoneal mesh position, such as TIPP. Based on the TIPP procedure, another preperitoneal
repair has been recently developed, the transrectus sheath preperitoneal (TREPP) mesh repair.
Methods: The ENTREPPMENT trial is a multicentre randomized clinical trial. Patients will be randomly allocated to
anterior inguinal hernia repair according to the TREPP mesh repair or TIPP procedure. All patients with a primary
unilateral inguinal hernia, eligible for operation, will be invited to participate in the trial. The primary outcome
measure will be the number of patients with postoperative chronic pain. Secondary outcome measures will be
serious adverse events (SAEs), including recurrence, hemorrhage, return to daily activities (for example work),
operative time and hospital stay. Alongside the trial health status, an economic evaluation will be performed. To
demonstrate that inguinal hernia repair according to the TREPP technique reduces the percentage of patients with
postoperative chronic pain from 12% to <6%, a sample size of 800 patients is required (two-sided test, α = 0.05,
80% power).The ENTREPPMENT trial aims to evaluate the TREPP and TIPP procedures from patients’ perspective. It is
hypothesized that the TREPP technique may reduce the number of patients with any form of postoperative chronic
pain by 50% compared to the TIPP procedure.
Trial registration: Current Controlled Trials: ISRCTN18591339.
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Background
An inguinal hernia has been reported as a common surgi-
cal problem. In The Netherlands, approximately 30,000
inguinal hernia repairs are performed each year [1].
Tension-free mesh repair has reduced the incidence of
recurrence (<5%) [2]. However, postoperative chronic
pain after inguinal hernia repair is the main complica-
tion, especially following Lichtenstein procedure [3-5].
Lichtenstein is the current reference technique for in-
guinal hernia repair [6]. The incidence of chronic pain
and (hypothetical) pathophysiological mechanisms of
chronic pain have been reported. Studies have shown
possible advantages in preperitoneal mesh positioning,
due to the lack of need for fixating the mesh. Further-
more, the approach in which the inguinal region with its
nerves is completely avoided during dissection resulted
in less patients with postoperative chronic pain [7,8].
The effect of the preperitoneal mesh position is in line
with those reported after total extraperitoneal (TEP)
and transabdominal preperitoneal (TAPP) procedures.
The transinguinal preperitoneal (TIPP) procedure has
been described as an alternative open preperitoneal mesh
repair [9,10]. Results of the TULIP trial, comparing TIPP
with the Lichtenstein procedure, concluded significantly
less patients with postoperative chronic pain after TIPP
in the first postoperative year [11]. Based on the TULIP
trial results and the low risk of bias methodology, the
TIPP procedure will be used as the control intervention
in this trial.
Based on the TIPP procedure, another open preperitoneal
mesh repair has been developed, the transrectus sheath
preperitoneal (TREPP) mesh repair. Description of the
technique and results of the first 50 TREPP cases have
been reported [12]. This pilot study showed promising
results for TREPP. The TREPP principles are: an open
technique, easy to learn, sutureless preperitoneal mesh
position, and avoiding the inguinal canal and inguinal
nerves peroperatively. These principles are in concordance
with the reported recommendations of Reinpold [13].
The aim of this randomized clinical trial is to evaluate
the TREPP and TIPP procedures. The trial design fo-
cuses on the three dimensions of possible errors: bias,
the ‘play of chance’ and the chosen outcome [14-16].
Methods
Prior to the start of the trial, the study protocol was
written and will be published. The ENTREPPMENT trial
is registered with the International Standard Randomised
Controlled Trial Number (ISRCTN) Register (http://
controlled-trials.com/ISRCTN18591339). The protocol
was ethically approved by the official Independent Review
Board Nijmegen (2012/060) and registered nationally
(NL38842.091.12) [17].
Design
The ENTREPPMENT trial will be a prospective ran-
domized multicentre trial. Two inguinal hernia repair
techniques, TREPP and TIPP, will be compared.
Patients will be included at the outpatient clinics of
the participating centers (Radboud University Nijmegen
Medical Centre, Nijmegen; St Elisabeth Hospital, Tilburg;
TweeSteden Hospital, Tilburg/Waalwijk; Gelderse Vallei
Hospital, Ede; and St Jansdal Hospital, Harderwijk) by
surgeons and supervised residents.
Prior to the start of the trial, group sessions in the
operation room (and by discussion) for complete stand-
ardization and uniformity of the TREPP and TIPP proce-
dures will be performed with the participating surgeons.
All surgeons will be assessed by an experienced colleague
(proctor) prior to their participation in the trial. The proc-
tors will decide whether the surgeon has completed the
learning curves of both techniques and can start the pro-
cedures in the trial.
Randomized patients will be operated on according to
this protocol. Dedicated hernia surgeons will perform
the operations or will supervise the residents. The same
mesh with memory ring will be used in both techniques
(Polysoft 16 × 9.5cm; Bard, Benelux, Belgium). The skin
will be closed intracutaneously.
Patients
Patients with a primary unilateral inguinal hernia, visit-
ing the outpatient clinics at the participating centers will
be invited to participate.
Inclusion criteria are: primary unilateral groin hernia,
aged between 18 and 80 years, American Society of
Anesthesiologists’ (ASA) classification 1 to 3, and signed
informed consent.
Exclusion criteria are: recurrent inguinal hernia, scrotal
hernia, femoral hernia, acute incarcerated inguinal hernia,
psychiatric disease, or other reasons making follow-up
or questionnaires unreliable, and previous preperitoneal
surgery, for example radical prostatectomy.
Intervention
The TREPP technique has been described [12]. To reach
the preperitoneal space (PPS), a 5 cm transverse incision
is made approximately 1 cm cranial to the pubic bone.
The anterior rectus sheath is opened by transverse inci-
sion. After retraction of the muscle fibers medially, the
inferior epigastric vein and artery are identified and
retracted medially. The underlying transverse fascia is
opened transversely as well. With a gentle movement,
the PPS is dissected and a medial hernia may be reduced
immediately. Using the iliac vessels as a landmark, the
funiculus is identified with the spermatic cord, the tes-
ticular vessels and a possible lateral hernia. The latter
(if present) may now be reduced. Using three long and
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thin retractors, a perfect overview of the PPS may be
achieved and all possible hernia orifices (medial, lateral
and/or femoral) can be visualized. The soft mesh is po-
sitioned in the PPS and covers the complete
myopectineal orifice of Fruchaud. After deployment,
the abdominal pressure keeps the mesh in position
without necessitating any fixation. The anterior rectus
sheath and the fascia of Scarpa are closed with Vicryl
(Ethicon, Livingston, UK).
Control intervention
The TIPP procedure has been described by Pelissier
[9,10] and evaluated in the TULIP trial [18]. In brief,
using the transinguinal approach, nerves will be identi-
fied and spared. The hernia sac is reduced into the PPS.
The PPS is dissected bluntly by a finger. A soft mesh
with memory ring is positioned in the PPS without the
need for fixation.
Outcome measures
The primary outcome measure will be the number of
patients with postoperative chronic pain. Chronic pain is
defined by the International Association for the Study
of Pain as any visual analog scale (VAS) score above
zero that lasts for more than 3 months postoperatively
[19]. To prevent the disadvantages of a single measure-
ment, postoperative chronic pain will be assessed at 6
and 12 months.
Secondary outcome measures are serious adverse events
(SAEs) during the first year after randomization. SAEs
are: death, irrespective of the cause; life-threatening event;
re-admission to the hospital; hemorrhage; wound infec-
tion, either surgical site or deep infection; and recurrence
(symptomatic) of the inguinal hernia. When in doubt
considering the seriousness of an event, a blinded expert
opinion will be obtained.
Other secondary outcome measures will be hospital
stay, operative time, numbness and return to daily activ-
ities. Alongside the trial, an economic evaluation and the
health status will be assessed.
Anesthesia and analgesia
Preoperatively, all patients will visit the anesthesiologist.
One analgesia protocol will be used in combination with
a standardized regimen regarding both postoperative pain
and nausea medication. These regimes are based on daily
practice; the standardization serves to avoid unneces-
sary bias. First choice of anesthesia technique is spinal
anesthesia, owing to its ease and expedited postopera-
tive recovery, avoiding the risks of general anesthesia
(nausea, tube, aspiration, heart/lung complications). If
the patient declines, general anesthesia will be permit-
ted. All anesthesiologists will be experienced with both
general and spinal anesthesia. The wound will be infil-
trated with 10 cc bupivacaine 0.1%.
Randomization and blinding
The randomization will be stratified by centre. Correct
generation of the allocation sequence, allocation con-
cealment, blinding and follow-up will be warranted. The
allocation sequence will be computer-generated. The trial
office will be contacted online prior to incision. The nurse
in the operating room will write down the technique for
the surgeon, so the patient will be unaware of the tech-
nique used. Operation reports will be blinded in the elec-
tronic patient files and no access will be allowed for the
outcome assessors. Plasters will be positioned identically
after both techniques. During follow-up, questionnaires
will be completed before contact with outcome assessors
and physical examination, to provide optimal masking.
Unblinding protocol
Patients will be informed on request about the performed
procedure only after completing the last follow-up visit.
Data recording and follow-up
All hernias will be classified according to the European
Hernia Society (EHS) hernia classification (Figure 1) [20].
All included patients will be interviewed preoperatively
according to the Pain Disability Index (PDI), Short Form
36 (SF-36) and EQ-5D. Preoperative pain scores will be
assessed by the Verbal Rating Scale (VRS) for pain. All
patients will keep a pain diary including the PDI and the
VRS for pain during the first 14 postoperative days.
The pinprick-test will be used to assess numbness in
the dermatomes related to the inguinal nerves on the
operated side. A figure of dermatomes will be used for
anatomical orientation [21].
Follow-up, including the three questionnaires and
a physical examination, will be scheduled at 14 days,
6 months and 1 year postoperatively.
EHS
Groin Hernia 
Classification
Primary Recurrent
0 1 2 3 x
L (lateral)
M (medial)
F (femoral)
Figure 1 European Hernia Society (EHS) groin hernia
classification [20].
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Ethics and informed consent
This study is conducted in concordance with the princi-
ples of the Declaration of Helsinki [22] and Good Clinical
Practice guidelines. The protocol was ethically approved
by the official Independent Review Board Nijmegen
(2012/060) and registered nationally (NL38842.091.12)
[17]. A Data and Safety Monitoring Board (DSMB) is
established to perform safety surveillance and to per-
form interim analyses on the safety data, as described.
Analysis and sample size
It is hypothesized that the TREPP technique reduces the
percentage of patients with any form of postoperative
chronic pain from 12% to 6%, or less. The TULIP trial
shows an incidence of patients with any form of postop-
erative chronic pain, either continuous or pain during
activity, of 12%. Step-up studies show postoperative
chronic pain after the TREPP technique, self-monitored
by patients and measured by a non-validated question-
naire, of 7% in a large undefined group.
Based on an absolute risk reduction from 12% to 6%, a
sample size of 720 patients is required (two-sided test,
α = 0.05, 80% power).
In order to compensate for possible loss to follow-up,
800 patients will be enrolled. The study end is expected
2.5 years after the start of the trial: 1.5 years of inclusion
and 1 year of follow-up. No interim analyses will be
planned.
Statistics
The analysis will be performed on the basis of the
intention-to-treat principle. Logistic regression with
centre as cofactor will be used to analyze binary out-
comes. Similarly, analysis of covariance with centre as
factor will be used to analyze continuous outcomes.
Skewed variables will be log transformed. A two-sided P
value of <0.05 will be considered to be significant and
95% confidence intervals will be calculated.
Reporting
The ENTREPPMENT trial findings will be graded to
facilitate critical decision making from the patients’
perspective according to the Grading of Recommenda-
tions Assessment, Development and Evaluation (GRADE)
Working Group (Figure 2) [15].
Figure 2 Example of the importance of outcomes from patients’ perspective according to GRADE 2008 [15].
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Study outcomes will be reported in concordance to the
recently updated Consolidated Standards of Reporting
Trials (CONSORT) checklist [23].
Trial status
Approved by the official Independent Review Board
Nijmegen (2012/060). Inclusion not started.
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